154 related articles for article (PubMed ID: 36178349)
1. Prediction of Histologic Neoadjuvant Chemotherapy Response in Osteosarcoma Using Pretherapeutic MRI Radiomics.
Bouhamama A; Leporq B; Khaled W; Nemeth A; Brahmi M; Dufau J; Marec-Bérard P; Drapé JL; Gouin F; Bertrand-Vasseur A; Blay JY; Beuf O; Pilleul F
Radiol Imaging Cancer; 2022 Sep; 4(5):e210107. PubMed ID: 36178349
[TBL] [Abstract][Full Text] [Related]
2. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
[TBL] [Abstract][Full Text] [Related]
3. Prediction of response to preoperative neoadjuvant chemotherapy in extremity high-grade osteosarcoma using X-ray and multiparametric MRI radiomics.
Luo Z; Li J; Liao Y; Huang W; Li Y; Shen X
J Xray Sci Technol; 2023; 31(3):611-626. PubMed ID: 37005907
[TBL] [Abstract][Full Text] [Related]
4. T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.
White LM; Atinga A; Naraghi AM; Lajkosz K; Wunder JS; Ferguson P; Tsoi K; Griffin A; Haider M
Skeletal Radiol; 2023 Mar; 52(3):553-564. PubMed ID: 35778618
[TBL] [Abstract][Full Text] [Related]
5. Automated prediction of the neoadjuvant chemotherapy response in osteosarcoma with deep learning and an MRI-based radiomics nomogram.
Zhong J; Zhang C; Hu Y; Zhang J; Liu Y; Si L; Xing Y; Ding D; Geng J; Jiao Q; Zhang H; Yang G; Yao W
Eur Radiol; 2022 Sep; 32(9):6196-6206. PubMed ID: 35364712
[TBL] [Abstract][Full Text] [Related]
6. [Prediction of chemotherapy response in primary osteosarcoma using the machine learning technique on radiomic data].
Dufau J; Bouhamama A; Leporq B; Malaureille L; Beuf O; Gouin F; Pilleul F; Marec-Berard P
Bull Cancer; 2019 Nov; 106(11):983-999. PubMed ID: 31587802
[TBL] [Abstract][Full Text] [Related]
7. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
[TBL] [Abstract][Full Text] [Related]
8. A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma.
Lin P; Yang PF; Chen S; Shao YY; Xu L; Wu Y; Teng W; Zhou XZ; Li BH; Luo C; Xu LM; Huang M; Niu TY; Ye ZM
Cancer Imaging; 2020 Jan; 20(1):7. PubMed ID: 31937372
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
Kalisvaart GM; Van Den Berghe T; Grootjans W; Lejoly M; Huysse WCJ; Bovée JVMG; Creytens D; Gelderblom H; Speetjens FM; Lapeire L; van de Sande MAJ; Sys G; de Geus-Oei LF; Verstraete KL; Bloem JL
Skeletal Radiol; 2024 Feb; 53(2):319-328. PubMed ID: 37464020
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
[TBL] [Abstract][Full Text] [Related]
11. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma.
Lee I; Byun BH; Lim I; Kim BI; Kong CB; Song WS; Cho WH; Koh JS; Lim SM
Medicine (Baltimore); 2018 Sep; 97(37):e12318. PubMed ID: 30212975
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy.
Zhang L; Ge Y; Gao Q; Zhao F; Cheng T; Li H; Xia Y
Front Oncol; 2021; 11():758921. PubMed ID: 34868973
[TBL] [Abstract][Full Text] [Related]
14. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
[TBL] [Abstract][Full Text] [Related]
15. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
16. Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI.
Byun BH; Kong CB; Lim I; Kim BI; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1553-62. PubMed ID: 24652233
[TBL] [Abstract][Full Text] [Related]
17. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
[TBL] [Abstract][Full Text] [Related]
18. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
[No Abstract] [Full Text] [Related]
19. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T.
Lee SK; Jee WH; Jung CK; Im SA; Chung NG; Chung YG
PLoS One; 2020; 15(3):e0229983. PubMed ID: 32155203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
